Focal laser application versus bevacizumab for treatment of central serous chorioretinopathy

Focal laser application versus bevacizumab for treatment of central serous chorioretinopathy

Aim To report and compare the efficacy of macular grid laser versus intravitreal bevacizumab injection (IVBI) in patients with central serous chorioretinopathy (CSCR). Patients and methods A prospective study on 36 eyes of 35 patients with CSCR was conducted. The diagnosis of CSCR was established by...

Full description

Bibliographic Details
Main Author: Ali A Ghali
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
bevacizmab
csr
laser
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2019;volume=17;issue=2;spage=132;epage=138;aulast=Ghali

Similar Items

Similar Items